Hyperlipoproteinemia, Type Iii (CAD)

Alias:

Hyperlipoproteinemia Type Iii

Broad-Betalipoproteinemia

Familial Type 3 Hyperlipoproteinemia

Floating-Betalipoproteinemia

Hyperlipemia with Familial Hypercholesterolemic Xanthomatosis

Coronary Artery Disease, Severe, Susceptibility to

Familial Hypercholesterolemia with Hyperlipemia

Familial Hyperbeta- and Prebetalipoproteinemia

Coronary Artery Disease, Severe

Familial Dyslipidemia Type 3

Remnant Hyperlipoproteinemia

Hyperlipoproteinemia Type 3

Coronary Artery Disease

Dysbetalipoproteinemia

Hyperlipidemia Type 3

Broad-Beta Disease

Broad Beta Disease

Hlp Type 3

Dysbetalipoproteinemia Due to Defect in Apolipoprotein E-D

Dysbetalipoproteinemia Due to Defect in Apolipoprotein E

Familial Hypercholesterolaemia with Hyperlipaemia

Apolipoprotein E, Deficiency or Defect of

Deficiency or Defect of Apolipoprotein E

Familial Hyperlipoproteinemia Type Iii

Carbohydrate Induced Hyperlipemia

Familial Dysbetalipoproteinemia

Coronary Arteriosclerosis

Coronary Heart Disease

Remnant Hyperlipidemia

Hyperlipoproteinemia 3

Hlpp3

Cad

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Hyperlipoproteinemia, Type Iii, also known as hyperlipoproteinemia type iii, is related to nonobstructive coronary artery disease and coronary heart disease 5, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Hyperlipoproteinemia, Type Iii is APOE (Apolipoprotein E), and among its related pathways/superpathways are Metabolism and Transport of inorganic cations/anions and amino acids/oligopeptides. The drugs Mycophenolic acid and Nitric Oxide have been mentioned in the context of this disorder. Affiliated tissues include heart and bone marrow, and related phenotypes are hypertriglyceridemia and increased ldl cholesterol concentration

Related ID：

MALACARDS：HYP724

OMIM：617347

MESH：D003324